Randomized Study of Weekly Erythropoietin Dosing in Preterm Infants
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
Preterm infants are a risk for multiple transfusions, and the administration of human
recombinant erythropoietin (Epo) has been shown to decrease transfusion requirements. Dosing
usually occurs three times a week, but extended dosing schedules have been successful in
adults. The investigators assessed weekly Epo dosing in preterm infants compared to standard
three times weekly dosing.